Impact of Abstinence and of Reducing Illicit Drug Use Without Abstinence on Human Immunodeficiency Virus Viral Load

Autor: Chinazo O. Cunningham, Michael J. Mugavero, Carlos del Rio, Lawrence J. Ouellet, Jane M. Simoni, Maria Esther Perez Trejo, Richard A. Kronmal, Richard D. Moore, Lauren N. Strand, Michael S. Saag, Kenneth H. Mayer, Robin M. Nance, Irene Kuo, Shoshana Y. Kahana, W. Chris Mathews, Joseph A.C. Delaney, Katerina Christopoulous, Heidi M. Crane, Geetanjali Chander, Rob J. Fredericksen, Vu Minh Quan, Curt G. Beckwith, Redonna K. Chandler, William E. Cunningham, Bridget M. Whitney, Jeremy D. Young, Ann E. Kurth, Faye S. Taxman, Mari M. Kitahata, Dennis M. Donovan, Sandra A. Springer, Fredrick L Altice, Joseph J. Eron
Rok vydání: 2019
Předmět:
Microbiology (medical)
Drug
viral suppression
medicine.medical_specialty
Substance-Related Disorders
media_common.quotation_subject
substance use
HIV Infections
Medical and Health Sciences
Microbiology
Methamphetamine
Heroin
Substance Misuse
03 medical and health sciences
0302 clinical medicine
Clinical Research
Internal medicine
Behavioral and Social Science
medicine
Humans
Longitudinal Studies
030212 general & internal medicine
abstinence
Articles and Commentaries
drug use
media_common
Harm reduction
030505 public health
Illicit Drugs
business.industry
Prevention
HIV
Odds ratio
Biological Sciences
Viral Load
Abstinence
medicine.disease
Substance abuse
Good Health and Well Being
Infectious Diseases
HIV/AIDS
heroin
Drug Abuse (NIDA only)
Infection
0305 other medical science
business
Viral load
medicine.drug
Zdroj: Clin Infect Dis
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, vol 70, iss 5
ISSN: 1537-6591
1058-4838
DOI: 10.1093/cid/ciz299
Popis: Background Substance use is common among people living with human immunodeficiency virus (PLWH) and a barrier to achieving viral suppression. Among PLWH who report illicit drug use, we evaluated associations between HIV viral load (VL) and reduced use of illicit opioids, methamphetamine/crystal, cocaine/crack, and marijuana, regardless of whether or not abstinence was achieved. Methods This was a longitudinal cohort study of PLWH from 7 HIV clinics or 4 clinical studies. We used joint longitudinal and survival models to examine the impact of decreasing drug use and of abstinence for each drug on viral suppression. We repeated analyses using linear mixed models to examine associations between change in frequency of drug use and VL. Results The number of PLWH who were using each drug at baseline ranged from n = 568 (illicit opioids) to n = 4272 (marijuana). Abstinence was associated with higher odds of viral suppression (odds ratio [OR], 1.4–2.2) and lower relative VL (ranging from 21% to 42% by drug) for all 4 drug categories. Reducing frequency of illicit opioid or methamphetamine/crystal use without abstinence was associated with VL suppression (OR, 2.2, 1.6, respectively). Reducing frequency of illicit opioid or methamphetamine/crystal use without abstinence was associated with lower relative VL (47%, 38%, respectively). Conclusions Abstinence was associated with viral suppression. In addition, reducing use of illicit opioids or methamphetamine/crystal, even without abstinence, was also associated with viral suppression. Our findings highlight the impact of reducing substance use, even when abstinence is not achieved, and the potential benefits of medications, behavioral interventions, and harm-reduction interventions.
Databáze: OpenAIRE